racemetirosine has been researched along with Cardiac Diseases in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahiskalioglu, A | 1 |
| Ince, I | 1 |
| Aksoy, M | 1 |
| Ahiskalioglu, EO | 1 |
| Comez, M | 1 |
| Dostbil, A | 1 |
| Celik, M | 1 |
| Alp, HH | 1 |
| Coskun, R | 1 |
| Taghizadehghalehjoughi, A | 1 |
| Suleyman, B | 1 |
1 other study available for racemetirosine and Cardiac Diseases
| Article | Year |
|---|---|
Comparative Investigation of Protective Effects of Metyrosine and Metoprolol Against Ketamine Cardiotoxicity in Rats.
Topics: alpha-Methyltyrosine; Animals; Antioxidants; Biomarkers; Cytoprotection; Disease Models, Animal; DNA | 2015 |